The key distinction at a glance
| Feature | H. Pylori Damage | Antibiotic Gut Damage |
|---|---|---|
| Location | Stomach — gastric mucosa | Entire gut — primarily intestinal |
| Mechanism | Direct bacterial NF-kB activation (CagA, LPS, urease) | Microbiome collapse → SCFA deficit + gram-negative LPS-NF-kB |
| Primary damage | Mucosal thinning, EGFR/ERK suppression, epithelial erosion | Tight junction degradation, mucosal permeability, immune dysregulation |
| Duration | Ongoing until bacteria are eradicated | 1–6 months post-course (microbiome recovery timeline) |
| Resolution | Antibiotic eradication + EGFR/ERK repair support | Probiotics + prebiotic fibre + NF-kB modulation + time |
H. pylori\'s damage pathway — focal and bacterial
H. pylori colonises the gastric mucosa specifically. Its damage is anatomically specific and driven by the bacteria's direct interaction with gastric epithelial cells. H. pylori injects its CagA virulence protein via a type IV secretion system directly into epithelial cells, activating NF-kB. Its outer membrane vesicles release LPS that binds TLR4, further activating NF-kB. Its urease produces ammonia that directly damages the mucosal surface. The consequence is sustained NF-kB signalling — driving cytokine release, immune cell recruitment, EGFR/ERK suppression, and progressive mucosal thinning. This process continues for as long as H. pylori remains present.
H. pylori activates NF-kB in gastric epithelial cells through CagA injection and LPS-TLR4 stimulation, producing a sustained pro-inflammatory cytokine cascade that drives mucosal damage and simultaneously suppresses the EGFR/ERK pathway responsible for mucosal repair — a stomach in chronic simultaneous damage and repair deficit.
Antibiotic gut damage — diffuse and ecological
Antibiotic-associated gut damage is structurally different. It is not caused by a bacterium directly attacking cells. It is caused by the absence of bacteria that were performing protective functions — and by the consequences of ecological collapse in the space they leave behind.
The four-stage dysbiosis cascade produces SCFA collapse, gram-negative expansion, LPS-driven intestinal NF-kB, and barrier degradation — all throughout the intestine rather than focused in the stomach. The damage is distributed, metabolic, and ecological rather than focal and bacterial.
This distinction matters for recovery. H. pylori damage partially resolves when H. pylori is eradicated — the bacterial NF-kB source is removed. Antibiotic damage does not resolve when the antibiotic course ends. The ecological disruption persists, and the metabolic cascade continues until the microbiome community rebuilds.
The convergence point — NF-kB, two different paths
Both H. pylori and antibiotic-induced dysbiosis activate NF-kB in gut epithelial cells — H. pylori through direct bacterial virulence (CagA, LPS), antibiotics through gram-negative LPS from the ecological vacuum. NF-kB is the shared convergence point. This is clinically significant: NF-kB inhibition (quercetin) addresses the downstream inflammatory endpoint regardless of which upstream pathway produced it.
The H. pylori eradication patient — both simultaneously
The patient undergoing H. pylori eradication triple therapy has both damage mechanisms operating simultaneously: the pre-existing H. pylori gastric mucosal damage (focal, bacterial, gastric), plus the direct mucosal irritation of the antibiotic compounds, plus the microbiome collapse from broad-spectrum antibiotic coverage. Three NF-kB sources, two anatomical locations, and two damage timelines — one resolving when eradication succeeds, one persisting for 1–6 months post-course.
This is why post-eradication recovery is the most complex gut repair scenario — and why mucosal repair support (EGFR/ERK activation + NF-kB inhibition) alongside microbiome recovery (probiotics + prebiotic fibre) matters most for this patient.
References
- Crowe SE. Helicobacter pylori infection. New England Journal of Medicine. 2019;380:1158–1165. PMID 30699316. H. pylori's CagA/LPS NF-kB mechanism — the focal bacterial damage pathway contrasted with antibiotic's ecological damage in this article.
- Sokol H et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium. PNAS. 2008;105(43):16731–16736. PMID 19066305. Establishes the ecological damage mechanism — the commensal bacteria whose loss drives the SCFA deficit and LPS-NF-kB cascade.
- Thursby E, Juge N. Introduction to the human gut microbiota. Biochemical Journal. 2017;474:1823–1836. PMID 28512250. Defines the intestinal barrier functions that the SCFA deficit from antibiotic dysbiosis compromises.